All articles by Andrew Hillman

Andrew Hillman is a data journalist at GlobalData Media, specialising in healthcare and pharmaceutical coverage. He is a graduate of Birmingham City University's data journalism program and previously worked as an analyst and modeller in the emergency healthcare sector.

Andrew Hillman


From a race to a crawl: How delays derailed Covid-19 vaccination in Africa

As we inch closer to the WHO’s deadline for vaccinating most of the world’s population, assessing the progress in many African countries requires nuance.

Tracking the rise of CAR-Ts in China: the dawn of an immunotherapy superpower?

Despite a slower start in the immuno-oncology arena, China appears to have surpassed its Western counterparts in building a strong research pipeline of specialised CAR-T therapies.

Molnupiravir supplies dominate in times of Paxlovid scarcity

While the US government is committed to buying 20m Paxlovid doses, deliveries have been slow compared to Merck’s molnupiravir.

Covid-19 antiviral access: uneven supply patterns hinder US rollout

An analysis of the demand for Covid-19 therapeutics allocation has shown that supply dynamics evolve slower than infection rates.

Filings buzz in pharma: 64% increase in internet of things mentions in Q2 of 2021

Internet of things mentions have increased 280% in the filings of companies in the pharmaceutical industry since 2016

Anaesthesia drugs worst-hit by US drug shortages

An analysis of FDA data shows the majority of drugs in short supply in the US are anaesthetics.

Filings buzz in pharmaceuticals: 34% decrease in industrial automation mentions in Q2 of 2021

Of the 50 biggest employers in pharma, Lonza Group referred to industrial automation the most between July 2020 and June 2021

Middle-income countries’ healthcare sectors to keep rising through to 2024

Healthcare provision markets of middle-income countries are set to climb at an average annual rate of 5.7% in the next three years.

Filings buzz in pharmaceuticals: 25% increase in robotics mentions since Q2 2020

The frequency of sentences related to robotics between July 2020 and June 2021 was 50% higher than in 2016.

Filings buzz in pharmaceuticals: 24% increase in artificial intelligence mentions in Q2 2021

Lupin Ltd was the company that referred to artificial intelligence the most between July 2020 and June 2021.